» Articles » PMID: 33804363

The Association of Bisphenol A and Phthalates with Risk of Breast Cancer: A Meta-Analysis

Overview
Publisher MDPI
Date 2021 Apr 3
PMID 33804363
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer is the most common cancer and the second leading cause of cancer-related death amongst American women. Endocrine-disrupting chemicals (EDCs), especially bisphenol A (BPA) and phthalates, have adverse effects on human health. However, the association of BPA and phthalates with breast cancer remains conflicting. This study aims to investigate the association of BPA and phthalates with breast cancer.

Methods: Correlative studies were identified by systematically searching three electronic databases, namely, PubMed, Web of Sciences, and Embase, up to November 2020. All data were analyzed using Stata 15.0.

Results: A total of nine studies, consisting of 7820 breast cancer cases and controls, were included. The urinary phthalate metabolite mono-benzyl phthalate (MBzP) and mono-2-isobutyl phthalate (MiBP) were negatively associated with breast cancer (OR = 0.73, 95% CI: 0.60-0.90; OR = 0.75, 95% CI: 0.58-0.98, respectively). However, the overall ORs for BPA, mono-ethyl phthalate (MEP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-2-ethylhexyl phthalate (MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono-(3-carboxypropyl) phthalate (MCPP), and mono-butyl phthalate (MBP) were 0.85 (95% CI: 0.69-1.05), 0.96 (95% CI: 0.62-1.48), 1.12 (95% CI: 0.88-1.42), 1.13 (95% CI: 0.74-1.73), 1.01 (95% CI: 0.74-1.40), 0.74 (95% CI: 0.48-1.14), and 0.80 (95% CI: 0.55-1.15), respectively, suggesting no significant association. The sensitivity analysis indicated that the results were relatively stable.

Conclusion: Phthalate metabolites MBzP and MiBP were passively associated with breast cancer, whereas no associations were found between BPA, MEP, MEHHP, MEHP, MEOHP, MCPP, and MBP and breast cancer. More high-quality case-control studies or persuasive cohort studies are urgently needed to draw the best conclusions.

Citing Articles

Bisphenol A and DDT disrupt adipocyte function in the mammary gland: implications for breast cancer risk and progression.

Bernhardt S, House C Front Oncol. 2025; 15:1490898.

PMID: 40034592 PMC: 11873108. DOI: 10.3389/fonc.2025.1490898.


Associations between phenol and paraben exposure and the risk of developing breast cancer in adult women: a cross-sectional study.

Xiong Y, Li Z, Xiong X, Luo Z, Zhong K, Hu J Sci Rep. 2025; 15(1):4038.

PMID: 39900803 PMC: 11791042. DOI: 10.1038/s41598-025-88765-z.


The AhR pathway regulation in phthalates-induced cancer promotion, progression and metastasis: a scoping review.

Akbariani M, Omidi M, Shahabi Z, Haghi-Aminjan H, Shadboorestan A Cancer Cell Int. 2025; 25(1):27.

PMID: 39875988 PMC: 11773746. DOI: 10.1186/s12935-024-03622-9.


Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Breast Cancer and Their Impact on Dietary Intake.

Singh D J Xenobiot. 2025; 15(1.

PMID: 39846533 PMC: 11755457. DOI: 10.3390/jox15010001.


The relationship between semen quality in male infertility clinic patients and bisphenol A:A Chinese cross-sectional study.

Tian Z, He Z, Zhang Q, Ding L, Song L, Ren R Heliyon. 2024; 10(16):e35982.

PMID: 39253254 PMC: 11381587. DOI: 10.1016/j.heliyon.2024.e35982.


References
1.
Parada Jr H, Gammon M, Ettore H, Chen J, Calafat A, Neugut A . Urinary concentrations of environmental phenols and their associations with breast cancer incidence and mortality following breast cancer. Environ Int. 2019; 130:104890. PMC: 6679996. DOI: 10.1016/j.envint.2019.05.084. View

2.
Supornsilchai V, Jantarat C, Nosoognoen W, Pornkunwilai S, Wacharasindhu S, Soder O . Increased levels of bisphenol A (BPA) in Thai girls with precocious puberty. J Pediatr Endocrinol Metab. 2016; 29(11):1233-1239. DOI: 10.1515/jpem-2015-0326. View

3.
Delfosse V, le Maire A, Balaguer P, Bourguet W . A structural perspective on nuclear receptors as targets of environmental compounds. Acta Pharmacol Sin. 2014; 36(1):88-101. PMC: 4571321. DOI: 10.1038/aps.2014.133. View

4.
Takashima K, Ito Y, Gonzalez F, Nakajima T . Different mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in wild-type and Ppar alpha-null mice. J Occup Health. 2008; 50(2):169-80. PMC: 7217336. DOI: 10.1539/joh.l7105. View

5.
Mueller E, Sarraf P, Tontonoz P, Evans R, Martin K, Zhang M . Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell. 1998; 1(3):465-70. DOI: 10.1016/s1097-2765(00)80047-7. View